Wasim Mansour
Family Medicine · El Cajon, CANPI 1649627696
Payments from drug & device makers
Across 212 payments — averaging $28.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceutical Holding Company Ltd.$2K
- Amgen$1K
- AbbVie$352
- Dexcom, Inc.$294
- Mannkind Corporation$253
- Lilly USA, LLC$249
- plus $2K from 28 others
What the payments were for
- Consulting fees$1,20020%
- Travel & lodging$2815%
- Food & beverage$4,54174%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $1,860 |
| Amgen | 45 | $1,130 |
| AbbVie(2 entities) | 17 | $352 |
| Dexcom, Inc. | 15 | $294 |
| Mannkind Corporation | 14 | $253 |
| Lilly USA, LLC | 14 | $249 |
| Astellas Pharma US Inc | 6 | $198 |
| Abbott | 10 | $190 |
| AstraZeneca | 10 | $185 |
| Esperion Therapeutics, Inc. | 10 | $180 |
| Novartis | 10 | $167 |
| Bayer | 4 | $137 |
| Boehringer Ingelheim | 6 | $111 |
| Pfizer | 6 | $111 |
| GSK | 4 | $84 |
| Viiv Healthcare Company | 2 | $68 |
| Novo Nordisk | 3 | $60 |
| Johnson & Johnson | 4 | $60 |
| Merck | 4 | $59 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $54 |
| Ironwood Pharmaceuticals, Inc | 2 | $37 |
| Sunovion Pharmaceuticals Inc. | 2 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| Corium, LLC | 1 | $24 |
| Lundbeck LLC | 1 | $22 |
| Corcept Therapeutics | 1 | $21 |
| Sumitomo Pharma America, Inc. | 2 | $21 |
| Therapeuticsmd, Inc. | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Optinose US, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Cipher Pharmaceuticals US LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,766
- Repatha$243
How this compares
$6,121 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 64 | $73,097 |
| OzempicSemaglutide | 65 | $67,409 |
| MounjaroTirzepatide | 45 | $48,079 |
| JanuviaSitagliptin Phosphate | 39 | $30,228 |
| Repatha SureclickEvolocumab | 41 | $24,794 |
| EliquisApixaban | 21 | $14,755 |
| JanumetSitagliptin Phos/Metformin Hcl | 11 | $10,808 |
| EntrestoSacubitril/Valsartan | 14 | $9,591 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 21 | $7,708 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 33 | $3,415 |
| Fenofibrate | 24 | $3,213 |
| Atorvastatin Calcium | 257 | $1,724 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 50 | $1,548 |
| Fluticasone Propionate | 65 | $833 |
| Metformin Hcl | 192 | $793 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $111 | $73,09764 claims |
| Novo NordiskOzempic | $60 | $67,40965 claims |
| Lilly USA, LLCMounjaro | $249 | $48,07945 claims |
| MerckJanuvia, Janumet | $59 | $41,03650 claims |
| PfizerEliquis | $111 | $14,75521 claims |
| NovartisEntresto | $167 | $9,59114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,533 family medicine providers in California.
Other family medicine in El Cajon
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.